Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN

Armistice Capital, LLC's stake in Supernus Pharmaceuticals, Inc. fell to 4.82% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Armistice Capital, LLC's stake in Supernus Pharmaceuticals, Inc. fell to 4.82%, 2,764,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
4.82%
Shares
2,764,000
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC4.82%2,764,000
Steven Boyd4.82%2,764,000

Source

View original at SEC

Related